The soy isoflavone equol enhances antigen-specific IgE production in ovalbumin-immunized BALB/c mice

Journal of Nutritional Science and Vitaminology

Volumn 56, Issue 1, 2010, Pages 72-76

  Sakai, Tohru ^a   Furoku, Sakina ^a   Nakamoto, Mariko ^a   Shuto, Emi ^a   Hosaka, Toshio ^a   Nishioka, Yasuhiko ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Equol; IgE; IL 13; Soy isoflavone

Indexed keywords

DAIDZEIN; EQUOL; ESTROGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN;

ANTIGEN SPECIFICITY; B LYMPHOCYTE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; MOUSE; NONHUMAN; NOTE; OVARIECTOMY; SOYBEAN; T LYMPHOCYTE;

MUS;

EID: 77954303591     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.56.72     Document Type: Note

References (27)

1. Tham DM, Gardner CD, Haskell WL. 1988. Potential health benefits of dietary phytoestrogens: epidemiological and mechanistic evidence. J Clin Endocrinol Metab 83: 2223-2235.
2. Anthony MS. 2000. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr 30: 662S-663S.
3. Anthony MS, Clarkson TB, Williams JK. 1998. Effect of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 68: 1390S-1393S.
4. Villegas R, Gao Y-T, Yang GG, Li H-L, Elasy TA, Zheng W, Shu XO. 2008. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 87: 162-167.
5. Ingram D, Sanders K, Kolybaba M, Lopez D. 1997. Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994.
6. Ganry O. 2005. Phytoestrogens and prostate cancer risk. Prev Med 41: 1-6.
7. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. 1998. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375S-1379S.
8. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J, Segre M, Allred CD, Helferich WG, Cooke PS. 2002. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA 99: 7616-7621.
9. Yellayi S, Zakroczymski MA, Selvaraj V, Valli VE, Ghanta V, Helferich WG, Cooke PS. 2003. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J Endocrinol 176: 267-274.
10. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. 2003. Genistein as an anti-inflammatory agent. Inflamm Res 52: 341-346.
11. Guo TL, McCay JA, Zhang LX, Brown RD, You L, Karrow NA, Germolec DR, White KL Jr. 2001. Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J Nutr 131: 3251-3258.
12. Guo TL, White KL Jr, Brown RD, Delclos KB, Newbold RR, Weis C, Germolec DR, McCay JA. 2002. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol 181: 219-227.
13. Setchell KD, Brown NM, Lydeking-Olsen E. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132: 3577-3584.
14. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. 2003. Bioavailability of phyto-oestrogens. Br J Nutr 89 (Suppl 1): 45S-58S.
15. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. 1995. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 208: 40-43.
16. Kogiso M, Sakai T, Mitsuya K, Komatsu T, Yamamoto S. 2006. Genistein suppresses antigen-specific immune responses through competition with 17ß-estradiol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 22: 802-809.
17. Mosman TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. 1986. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357.
18. Mosman TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secrestion lead to different functional properties. Annu Rev Immunol 7: 145-173.
19. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P. 1990. Eosinophilic inflammation in ashma. N Engl J Med 323: 1033-1039.
20. Sutton BJ, Gould HJ. 1993. The human IgE network. Nature 366: 421-428.
21. Kuhn R, Rajewsky K, Muller W. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254: 707-710.
22. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R, Mckenzie ANJ. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9: 423-432.
23. Park J, Kim SH, Cho D, Kim TS. 2005. Formononetin, a phyto-oestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity. Immunology 116: 71-81.
24. Maret A, Coudert JD, Garidou LG, Foucras G, Gourdy P, Krust A, Dupont S, Chambon P, Druet P, Bayard F, Guèry J-C. 2003. Estradiol enhances primary antigen-specific CD4 T cell response and Th1 development in vivo: essential role of estrogen receptor a expression in hematopoietic cells. Eur J Immunol 33: 512-521.
25. Marito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. 2001. Interaction of phytoestrogens with estrogen receptors a and ß. Bio Pharm Bull 24: 351-356.
26. Mitchell JM, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. 1998. Antioxidant efficacy of phytoestrogens in chemical and biological model system. Arch Biochem Biophys 360: 142-148.
27. Arora A, Nair MG, Strasburg GM. 1998. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356: 133-141.